Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of rTMS on BDNF and proBDNF Levels: a Sham-controlled Study in Subjects With Cocaine Use Disorder

NCT05824221 is registered in ClinicalTrials.gov with ITAB - Institute for Advanced Biomedical Technologies as lead sponsor.

NCT NCT05824221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05824221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of rTMS on BDNF and proBDNF Levels: a Sham-controlled Study in Subjects With Cocaine Use Disorder
Lead sponsor
ITAB - Institute for Advanced Biomedical Technologies
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2023
Completion date
October 31, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine abuse, cocaine dependence, cocaine use, neurotropism